General Information of the Compound
Compound ID |
CP0908149
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
LEVOCETIRIZINE DIHYDROCHLORIDE
Show/Hide
|
||||||||||||||||||
Synonyms |
(2-(4-((R)-(4-Chlorophenyl)phenylmethyl)piperazin-1-yl)ethoxy)acetic acid dihydrochloride
Acetic acid, (2-(4-((R)-(4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, dihydrochloride
KS-1177
Levocetirizine 2HCl
Levocetirizine HCl
Levocetirizine dihydrochloride
Levocetirizine dihydrochloride [USAN]
Levocetirizine hydrochloride
Levocetirizine hydrochloride (JAN)
Vozet (TN)
Xozal (TN)
Xusal (TN)
Xuzal (TN)
Xyzal
Xyzal (TN)
Xyzall
Xyzall (TN)
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C21H27Cl3N2O3
|
||||||||||||||||||
Molecular Weight |
461.817
|
||||||||||||||||||
Canonical SMILES |
Cl.Cl.O=C(O)COCCN1CCN([C@H](c2ccccc2)c2ccc(Cl)cc2)CC1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C21H25ClN2O3.2ClH/c22-19-8-6-18(7-9-19)21(17-4-2-1-3-5-17)24-12-10-23(11-13-24)14-15-27-16-20(25)26;;/h1-9,21H,10-16H2,(H,25,26);2*1H/t21-;;/m1../s1
Show/Hide
|
||||||||||||||||||
InChIKey |
PGLIUCLTXOYQMV-GHVWMZMZSA-N
|
||||||||||||||||||
CAS |
130018-87-0
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound